Clinical Trials Logo

Filter by:
NCT ID: NCT05289869 Completed - Clinical trials for Pregnant Patients With Obesity

A Pilot Study: High Versus Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity

HILIO-PILOT
Start date: April 6, 2022
Phase: Phase 4
Study type: Interventional

Pregnant patients with obesity are more likely to undergo induction of labor and have a higher risk of failed induction compared to patients with normal weight. The association between maternal obesity and labor dysfunction leading to cesarean delivery is poorly understood. Oxytocin is the mostly common medication used in induction of labor, yet optimal dosing of this medication is unknown. Studies have suggested that patients with obesity may be less responsive to oxytocin. This trial will compare a high and low dose oxytocin dosing regimen for the induction of labor in women with obesity.

NCT ID: NCT05289596 Completed - Anxiety Clinical Trials

Sleep Well: Digital Insomnia Treatment Program For Physicians

Start date: February 4, 2022
Phase: N/A
Study type: Interventional

Sleep disturbance is risk factor for incident depression and remains a leading concern for physician burnout; as sleep plays a fundamental role in mood, stress, and cognition, including medical errors. The goal of this project is to implement an evidence-based digital therapy to treat insomnia (Sleep Healthy Using the Internet (SHUTi) for physicians to improve both sleep and mental health outcomes. The investigators will evaluate both process and individual-outcome metrics to define success. Individual level outcomes will be assessed pre-program (at start of participation), week 8 (end-program), and week 16 (2-month follow-up). This information will enable us to design larger future implementation initiatives for the healthy sleep program across the hospital, should the pilot be successful.

NCT ID: NCT05289180 Completed - Clinical trials for Heart Transplantation

Brachial Right Ventricle - Endomyocardial Biopsy

Start date: October 24, 2022
Phase:
Study type: Observational

This is an observational study that will recruit NYU Langone patients undergoing standard of care right ventricle endomyocardial biopsy. Patients who undergo planned RV-EMB via transbrachial access will be invited to take part in the study.

NCT ID: NCT05289089 Completed - Clinical trials for Irritable Bowel Syndrome

Well-being in IBS: Strengths and Happiness (WISH)

Start date: March 25, 2022
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to examine the feasibility, acceptability, and preliminary efficacy of a customized positive psychology (PP) intervention for patients with irritable bowel syndrome (IBS) compared to a wait list control group.

NCT ID: NCT05289037 Completed - COVID-19 Clinical Trials

COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

Start date: March 30, 2022
Phase: Phase 2
Study type: Interventional

This phase 2 clinical trial will evaluate the safety and immunogenicity of additional doses of prototype and variant (alone or in combination) vaccine candidates in previously vaccinated participants with or without prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and will evaluate innate, cellular, and humoral immune responses to inform on how to shift the immune response to cover new variants as they emerge. A randomized open-label, non-placebo controlled, multi-site, multi-stage clinical trial in individuals, 18 years of age and older, who are in a stable state of health, has received a complete authorized/approved vaccine series (primary series + booster either with homologous or heterologous vaccine products) >/ = 16 weeks prior to enrollment. Subjects will be stratified by i) age (18-64 years and = 65 years of age) (however arms 16 and 17 or stage 4 will only enroll participants between the ages of 18-49 years) and ii) history of confirmed prior SARS-CoV-2 infection, and randomly assigned to receive one of several variant vaccines. Enrollment will target a goal of approximately 45% of each of the variant vaccine arms to be in older adults (= 65 years of age) for stages 1, 2 and 3 and approximately 20% to have had confirmed COVID-19 for all 4 stages. The primary objective is to evaluate humoral immune responses of candidate SARS-CoV-2 variant vaccines, alone or in combination.

NCT ID: NCT05289024 Completed - Clinical trials for Non-pharmacologic Management of Chronic Pain

Pragmatic Implementation of Mindful Awareness in Body Oriented Therapy

Start date: July 1, 2022
Phase:
Study type: Observational

This is a one group study using a hybrid implementation design.

NCT ID: NCT05288907 Completed - Pruritus Ani Clinical Trials

SOOTHER Trial to Treat Rectal Itch

Start date: September 1, 2018
Phase:
Study type: Observational

Longitudinal, observational, single-arm trial of a novel, composite Lidocaine ointment to treat rectal itch (pruritus ani)

NCT ID: NCT05288582 Completed - Dry Eye Clinical Trials

Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops

Start date: March 27, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the tear lipid layer quantitatively and qualitatively before and after use of a perflurohexyloctane eye drop (NovaTears)

NCT ID: NCT05288517 Completed - Clinical trials for Suicide and Self-harm

A Randomized Control Trial of a Digital Health Tool

L2L
Start date: April 19, 2021
Phase: N/A
Study type: Interventional

This randomized trial evaluated whether sending population-based invitation messages through the electronic health record to visit Lock to Live (L2L), a web-based decision aid that incorporates patients' values into recommendations for safe storage of firearms and medications, impacted readiness to change firearm and medication storage behaviors.

NCT ID: NCT05288504 Completed - Clinical trials for Non-Eosinophilic Asthma

A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.

Start date: February 24, 2022
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of AVTX-002 compared with placebo in patients with poorly controlled non-eosinophilic asthma (NEA).